A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's ...

Researchers have identified a blood protein ‘signature’ in the complement system, part of the immune system, of patients with long COVID that may improve the diagnosis and lead to a treatment ...

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce ...

The complement system plays a part in glomerular disease. There are two main forms of glomerular disease: dense deposit disease and C3 glomerulonephritis. Learn more about them both.

The findings suggest a dysregulation of the complement pathway, a part of the immune system, and the blood clotting pathways in individuals with long COVID at six months.

C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) are two rare kidney diseases. They’re both driven by activity of the complement system ...

Regeneron’s cemdisiran, used alone or in combination with its complement inhibitor Veopoz, significantly improved activities ...

Aptamer Group plc has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies.

Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer—activation of the complement system. A new article in ...

Disruption of the complement system appears to precede the onset of islet autoimmunity (IA), making it a potential early warning sign of type 1 diabetes (T1D), according to a new report.